| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/01/2004 | WO2003099225A3 Compositions for delivering nucleic acids to cells |
| 04/01/2004 | WO2003097825A3 Novel phospholipases and uses thereof |
| 04/01/2004 | WO2003094857A3 Stimulation by toll-like receptors inhibits osteoclast differentiation |
| 04/01/2004 | WO2003093442A3 Cell cultures from animal models of alzheimer's disease for screening and testing drug efficacy |
| 04/01/2004 | WO2003084385A3 Redifferentiated cells for repairing cartilage defects |
| 04/01/2004 | WO2003078596A3 Methods and devices for selective disruption of fatty tissue by controlled cooling |
| 04/01/2004 | WO2003078588A3 Primitive and proximal hepatic stem cells |
| 04/01/2004 | WO2003075953A3 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 04/01/2004 | WO2003074078A3 Cg3842 homologous proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003070907A3 Novel fungal lipase |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003063792A3 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003050283A3 A structure for presenting desired peptide sequences |
| 04/01/2004 | WO2003048336A3 Cultured cells from pancreatic islets |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003030965A3 Artificial lymph node |
| 04/01/2004 | WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/01/2004 | WO2003024989A9 Activation and expansion of cells |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | WO2002092758A3 Gastrokines and derived peptides including inhibitors |
| 04/01/2004 | WO2002085286A3 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002077012A3 Human papilloma virus immunoreative peptides |
| 04/01/2004 | WO2002064631A3 T1r taste receptors and genes encoding same |
| 04/01/2004 | WO2002064131A3 Inflammation-inhibiting compounds |
| 04/01/2004 | WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 04/01/2004 | US20040064859 Transgenic seeds for propagating herbicide, insect and disease resistance plants; tissue engineering |
| 04/01/2004 | US20040064858 Spression of specific classes of soybean seed protein |
| 04/01/2004 | US20040064850 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 04/01/2004 | US20040064849 Use of genes encoding membrane transporter pumps to stimulate the production of secondary metabolites in biological cells |
| 04/01/2004 | US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides |
| 04/01/2004 | US20040064842 Using dispersed regulatory nucleotide sequences to regulate transcription in animal cells, tissues and/or organs; gene expression inhibition |
| 04/01/2004 | US20040064013 Incubator and incubation method monitoring the organism to be incubated |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 04/01/2004 | US20040063909 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders |
| 04/01/2004 | US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/01/2004 | US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression |
| 04/01/2004 | US20040063206 Preparing lyophilized hydrogel of crosslinked alginate or hyaluronic acid for high throughput screening and tissue engineering |
| 04/01/2004 | US20040063205 Nutrient broth for propagation mammalian tissue models for use in nutraceutical discovery, drug screening, pharmacokinetics and transplantation studies |
| 04/01/2004 | US20040063204 Insulin-producing cell isolated from in vitro culture of bone marrow cells for reducing hyperglycemia in diabetic animal; antidiabetic agents |
| 04/01/2004 | US20040063203 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 04/01/2004 | US20040063202 Neurogenesis from hepatic stem cells |
| 04/01/2004 | US20040063201 Controlling lineage development in an in vitro human tissue system for bone marrow transplantation |
| 04/01/2004 | US20040063200 Biological component comprising artificial membrane |
| 04/01/2004 | US20040063199 Patterning nanofeatures over large areas |
| 04/01/2004 | US20040063188 Kit for treating gastrointestinal tract |
| 04/01/2004 | US20040063186 Vectors and methods for recombinant protein expression |
| 04/01/2004 | US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l |
| 04/01/2004 | US20040063177 Generating subtilisin mutant with decreased immunogenicity for use in laundry detergents, cosmetics and textile treatment |
| 04/01/2004 | US20040063175 Transgenic cell for preparation of monatin; food and beverage sweetening |
| 04/01/2004 | US20040063173 Hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 04/01/2004 | US20040063164 Kit and method for detecting the esm-1 protein |
| 04/01/2004 | US20040063145 Transcription factor comprising bromodomain for diagnosis and treatment of leukemia |
| 04/01/2004 | US20040063143 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis |
| 04/01/2004 | US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063092 Immunoassays for anti-HCV antibodies |
| 04/01/2004 | US20040062882 Bonding hyaluronic acid to polypeptide; immobilization |
| 04/01/2004 | US20040062843 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent |
| 04/01/2004 | US20040062775 Nucleotide sequences; veterinary medicine; vaccine |
| 04/01/2004 | US20040062772 Attenuated live neospora vaccine |
| 04/01/2004 | US20040062766 Cell separation compositions and methods |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062756 Genetic engineering; hematopoietic or stem cells; binding lentivirus vector to cell surfaces |
| 04/01/2004 | US20040062755 Liquid culture product; tissue engineering |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 04/01/2004 | CA2695720A1 Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/01/2004 | CA2695671A1 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | CA2499625A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | CA2499467A1 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | CA2499386A1 High titer recombinant aav production |
| 04/01/2004 | CA2499385A1 Modified adenoviral vectors for use in vaccines and gene therapy |
| 04/01/2004 | CA2498881A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
| 04/01/2004 | CA2498711A1 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells |
| 04/01/2004 | CA2497635A1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | CA2474680A1 Method for analyzing organelle-localized protein and material for analysis |
| 03/31/2004 | EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 03/31/2004 | EP1403376A2 Expression of heterologous genes according to a targeted expression profile |
| 03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 03/31/2004 | EP1403285A1 Fibroblast growth factor receptors |
| 03/31/2004 | EP1402901A1 Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction |
| 03/31/2004 | EP1402262A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402076A2 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 03/31/2004 | EP1402067A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402051A2 Lces as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402048A2 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402035A2 G-protein coupled receptors and dna sequences thereof |
| 03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |